Geode Capital Management’s Evoke Pharma EVOK Stock Holding History

Geode Capital Management’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,141	Closed	-$26.3K	–	4552
2024 Q2	$26.3K	Buy	4,141 +1,886	+84%	+$11.4K	﹤0.01%	4408
2024 Q1	$16.5K	Hold	2,255	–	–	﹤0.01%	4504
2023 Q4	$28.4K	Hold	2,255	–	–	﹤0.01%	4456
2023 Q3	$37.1K	Buy	2,255 +514	+30%	+$8.42K	﹤0.01%	4493
2023 Q2	$34.3K	Hold	1,741	–	–	﹤0.01%	4584
2023 Q1	$39.7K	Hold	1,741	–	–	﹤0.01%	4567
2022 Q4	$55K	Hold	1,741	–	–	﹤0.01%	4569
2022 Q3	$39K	Hold	1,741	–	–	﹤0.01%	4812
2022 Q2	$67K	Buy	1,741 +193	+12%	+$9.2K	﹤0.01%	4703
2022 Q1	$110K	Buy	1,548 +89	+6%	+$7.1K	﹤0.01%	4625
2021 Q4	$117K	Sell	1,459 -168	-10%	-$23.5K	﹤0.01%	4672
2021 Q3	$304K	Buy	1,627 +268	+20%	+$45.2K	﹤0.01%	4263
2021 Q2	$268K	Buy	1,359 +248	+22%	+$53.1K	﹤0.01%	4213
2021 Q1	$292K	Hold	1,111	–	–	﹤0.01%	4002
2020 Q4	$412K	Buy	1,111 +41	+4%	+$21.1K	﹤0.01%	3650
2020 Q3	$722K	Sell	1,070 -239	-18%	-$152K	﹤0.01%	3314
2020 Q2	$667K	Sell	1,309 -108	-8%	-$30K	﹤0.01%	3274
2020 Q1	$236K	Buy	1,417 +12	+0.9%	+$2.31K	﹤0.01%	3495
2019 Q4	$327K	Buy	1,405 +18	+1%	+$3.08K	﹤0.01%	3643
2019 Q3	$171K	Buy	1,387 +641	+86%	+$85.9K	﹤0.01%	3828
2019 Q2	$67K	Buy	746 +586	+366%	+$58.1K	﹤0.01%	4031
2019 Q1	$34K	Hold	160	–	–	﹤0.01%	4059
2018 Q4	$57K	Hold	160	–	–	﹤0.01%	3968
2018 Q3	$68K	Hold	160	–	–	﹤0.01%	3990
2018 Q2	$57K	Hold	160	–	–	﹤0.01%	3964
2018 Q1	$47K	Hold	160	–	–	﹤0.01%	3955
2017 Q4	$52K	Hold	160	–	–	﹤0.01%	3920
2017 Q3	$76K	Hold	160	–	–	﹤0.01%	3868
2017 Q2	$59K	Hold	160	–	–	﹤0.01%	3926
2017 Q1	$71K	Buy	160 +50	+45%	+$20.5K	﹤0.01%	3886
2016 Q4	$32K	Hold	110	–	–	﹤0.01%	3967
2016 Q3	$35K	Hold	110	–	–	﹤0.01%	3948
2016 Q2	$108K	Hold	110	–	–	﹤0.01%	3777
2016 Q1	$80	Hold	110	–	–	﹤0.01%	3890
2015 Q4	$52K	Hold	110	–	–	﹤0.01%	3997
2015 Q3	$46K	Hold	110	–	–	﹤0.01%	4019
2015 Q2	$82K	Hold	110	–	–	﹤0.01%	3805
2015 Q1	$111K	Hold	110	–	–	﹤0.01%	3738
2014 Q4	$93K	Buy	110 +39	+55%	+$32.2K	﹤0.01%	3800
2014 Q3	$56K	Hold	71	–	–	﹤0.01%	3825
2014 Q2	$80K	Hold	71	–	–	﹤0.01%	3725
2014 Q1	$85K	Buy	+71	New	+$101K	﹤0.01%	3690

Other funds holding EVOK

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Geode Capital Management's EVOK Position: Q3 2024 in Review

Geode Capital Management sold out of Evoke Pharma (EVOK) in Q3 2024, closing a stake of 4,141 shares — an estimated $26.3K sold.

Geode Capital Management first reported a position in EVOK in Q1 2014 and held it in 42 quarters. The position peaked at $722K in Q3 2020. 12 funds tracked by Wall St. Rank hold EVOK as of Q3 2024.

Geode Capital Management reported no remaining Evoke Pharma position as of Q3 2024 after selling out during the quarter.
Geode Capital Management sold 4,141 Evoke Pharma shares in Q3 2024, an estimated $26.3K.
Geode Capital Management first reported a position in Evoke Pharma in Q1 2014 and held it in 42 quarters.
Geode Capital Management's Evoke Pharma position peaked at $722K in Q3 2020.
12 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.